Follow us on LinkedIn - https://www.linkedin.com/company/fatty-liver-alliance/
Follow us on LinkedIn - https://www.linkedin.com/company/fatty-liver-alliance/
Signed in as:
filler@godaddy.com
There's much to see here. So, take your time, look around, and learn all about Fatty Liver Disease. We hope you enjoy our site and take a moment to drop us a line.
Let is know what else we can to help you learn more about MASLD and MASH (NAFLD and NASH)
Empowering Patients with Knowledge
"Liver Insights Part 2" is focused on equipping patients with approachable and comprehensive knowledge about MASLD and MASH. By breaking down complex medical information into accessible and actionable insights, this series enables patients to feel empowered, manage their health proactively, and make informed decisions in collaboration with their healthcare providers.
Thank you Madrigal Pharmaceuticals for the sponsorship of this educational programming.
Introduction to MASLD & MASH:
What Every Patient Should Know
A clear, easy-to-understand overview of MASLD and MASH, covering what these terms mean, how the liver functions, and the significance of a MASH diagnosis. With special guest, Dr. Sonal Kumar, Hepatologist.
Part 2: MASLD & MASH: Understanding the Basics: Disease Stages and Progression
A guide to understanding the stages of MASLD and MASH, including what each stage means for liver health and how to recognize symptoms at each stage. This episode helps patients understand the potential progression of disease, emphasizing that management is possible at each stage. With special guest, Dr. Mazen Noureddin, Hepatologist.
Part 3: Liver Insights 2: Understanding and Managing Symptoms of MASLD and MASH
Learn how to recognize and manage symptoms of MASLD and MASH with insights from Dr. Meena Bonsal, a leading hepatologist. This video offers practical advice on tracking symptoms, addressing co-existing conditions, and improving your well-being through tailored care. Take control of your liver health today!
Lifestyle Modifications that Make a Difference with MASLD and MASH
In an insightful discussion with Dr. Jonathan Stine, learn practical and achievable lifestyle changes, including dietary adjustments, alcohol moderation, and simple physical activity tips. This episode focuses on realistic goals and offer small steps that can be integrated into daily life without feeling overwhelming.
Your Lab Results Explained: Making Sense of Blood Work and Scans
Helping patients interpret common lab results like ALT, AST, FibroScan, ELF, and MRI-PDFF scores. Patients frequently receive test results without fully understanding them, so this episode would provide guidance on how to interpret these numbers and how they relate to their liver health. Dr. Jorn Schattenberg, Hepatologist, Hamburg, Germany shares his experience.
Building a Support Team: Healthcare Providers, Family, and Beyond
Exploring the roles of different healthcare providers (e.g., hepatologists, dietitians, primary care physicians) and tips on engaging family and friends in the journey. Having a support system can make a big difference in managing MASLD and MASH, and this episode with Dr. Manel Abdelmalek would provide advice on building and maintaining this team.
The Role of Diet in MASLD and MASH
Professor Shira Zelber-Sagi emphasized that diet is the foundation of MASLD and MASH management. Poor dietary habits contribute significantly to liver fat accumulation, inflammation, fibrosis, and even liver cancer. While many believe that weight loss alone is the key, diet quality is just as important. "If you don’t take care of your liver, it won’t take care of you." – Prof. Shira Zelber-Sagi
Finding Strength and Support: Living with MASLD and MASH
The Emotional Impact of a Diagnosis: For many, the initial shock of diagnosis can lead to a whirlwind of emotions—fear, anxiety, confusion, and sometimes even guilt. Gina Villiotti-Madison, Executive Director of Liver Education Advocates, shared during our recent Liver Insights II series that it is normal to feel this way. She emphasized that while it is okay to sit with these feelings briefly, finding a path forward is crucial.
How to Advocate for Yourself as a MASLD/MASH Patient
If you’ve been diagnosed with Metabolic dysfunction-Associated Steatotic Liver Disease (MASLD) or Metabolic dysfunction-Associated Steatohepatitis (MASH), you might feel overwhelmed or unsure about what comes next. But here’s the truth: you are your own best advocate in the healthcare system. In a recent conversation between Michael Betel, President of the Fatty Liver Alliance, and Dr. Supriya Joshi, a Hepatologist and patient advocate, we explored how patients can take control of their healthcare journey. Here are the key takeaways and practical steps to help you advocate for yourself effectively.
Taking Action: Current and Emerging Treatments for MASH
In this discussion, Michael Betel, President and Founder of the Fatty Liver Alliance, and Dr. Naim Alkhouri, a transplant hepatologist and Director of the Fatty Liver Program at Arizona Liver Health, explore the current and emerging treatment options for MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease) and MASH (Metabolic Dysfunction-Associated Steatohepatitis).
What happens when the community has an opportunity to see, feel and really understand liver disease from a realitistic liver model?
Millions are affected by fatty liver disease, and raising awareness is crucial. Wendy Schaufert has dedicated 10 years to working with patients, focusing on metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH), formerly NAFLD/NASH.
What are MASLD and MASH? Can they be prevented? Is treatment available?
Understanding MASLD and MASH: Dr. Swain provided an in-depth explanation of Metabolic dysfunction-Associated Steatotic Liver Disease (MASLD) and Metabolic dysfunction-Associated Steatohepatitis (MASH), highlighting the importance of recognizing and addressing these conditions early.
What do MASLD and MASH look like? What do they feel like? Check out the interest from the Calgary, AB community.
Liam Swain sharing the Madrigal Pharmaceuticals liver model on Global Fatty Liver Day.
Your Liver Your Health: Understanding MASLD, MASH, Diabetes and Your Metabolic Health with Michael Betel
What do the stages of liver disease look like and feel like? (Thank you Madrigal Pharmaceuticals for the use of the liver models.
"How often do you think about your liver?"
Diagnosing Fatty Liver Disease
Fatty Liver Disease from a Patient's Perspective
TORONTO, Sept. 22, 2023 (GLOBE NEWSWIRE) -- On the evening of September 19, 2023, the Fatty Liver Alliance, a Canadian not-for-profit charity, hosted, at the Westmount Public Library, in Westmount, Quebec, an extraordinary event that saw an overwhelming turnout of 50 community members.
Louise Campbell shows how easy a Fibroscan can be for patients and that there is nothing to be afraid of.
Your liver is an incredible organ, performing more than 500 vital functions, such as filtering toxins and aiding in digestion and metabolism. Yet, liver health is often overlooked.
Each year, thousands of people are affected by liver disease. 1.5 billion people live with chronic liver disease, and 2 million lives are lost yearly. Early prevention can save many of these lives.
World Liver Day aims to spotlight the rising burden of liver diseases and the urgent need for concerted global action.
Beginning as a national effort in India, it has now become a worldwide movement, connecting people from every continent, including communities, doctors, and policymakers to promote liver health.
For Fatty Liver Disease, now more commonly known as Metabolic dysfunction-Associated Steatotic Liver Disease (MASLD), a roadmap of actions and priorities has been published and will help address this epidemic.
1) Research priorities in SLD (JHEP, 2023): https://doi.org/10.1016/j.jhep.2023.04.035
2) Action priorities in SLD (Hepatology, 2024):
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.